Since we showed that both FGF23 and TGF-β signaling is activated in CF-HBEC, we treated both HBECs and CF-HBECs with either human recombinant FGF23, TGF-β or both for 24 hours and assessed IL-8 mRNA levels. Here, FGF23 is linked to cystic fibrosis.